2017 News Briefs - International Neuromodulation Society

Earlier News:


January 2017

Study Investigates Deep Brain Stimulation for Anorexia Nervosa

Feb. 24, 2017 - A study of 16 patients with anorexia nervosa who had deep brain stimulation to their subcallosal cingulate showed the intervention was safe and might help improve their symptoms, according to data published in The Lancet Psychiatry. (Medical Xpress)

Chronic Pain Patients Simulation Preferences Varied in Neurostimulation Clinical Trial

Feb. 23, 2017 - International Neuromodulation Society member Frank Huygen, MD, PhD and colleagues report in the European Journal of Pain that a multi-center, cross-over trial of five different types of stimulation in 29 patients with complex regional pain syndrome showed 48% preferred the standard frequency of stimulation and 54% preferred a non-standard one. (Neuro News)

Company Announces U.S. Patents for Its Sacral Neuromodulation System

Feb. 23, 2017 - Axionics Modulation Technologies, Inc. announced issuance of four U.S. patents related to the company's implantable sacral nerve stimulation technology. (Yahoo Finance)

Company Announces First European Implants of Its Neurostimulator for Peripheral Neuralgias

Feb. 22, 2017 - Bioness, Inc. announced a series of the first implantations of its percutaneous peripheral nerve stimulation system at medical centers in the Netherlands, Ireland, and Belgium. (Yahoo Finance)

Cognitive Training Improved Slightly with Transcranial Direct Current Stimulation in Home Study of Multiple Sclerosis Patients

Feb. 22, 2017 - A feasibility study of multiple sclerosis patients showed modest improvements from receiving transcranial direct current stimulation during 10 sessions of computer-based cognitive-training at home, while they were remotely monitored through video-conferencing. Compared to 20 patients who only received cognitive training, 25 patients who received simultaneous stimulation improved modestly in performance scores for complex attention tasks and reaction times. The results were published in Neuromodulation: Technology at the Neural Interface. (Mass Device)

Bioelectric Medicine Center Receives $25 Million Donation

Feb. 21, 2017 - The Feinstein Institute for Medical Research, which pursues research in bioelectric medicine, received A $25 million donation from philanthropists Leonard and Susan Feinstein, whose donation follows a $25 million donation in 2005 that led to the institute's renaming in their honor. (Innovate LI)

Review Examines Studies of Non-Invasive Stimulation in Stroke

Feb. 21, 2017 - A review about the safety of transcranial direct current stimulation (tDCS) in stroke rehabilitation says studies should describe exclusion criteria and induced adverse effects, in order to facilitate examination of factors that may induce side effects. Less than 12% of papers published between 1998 and 2015 reported adverse effects of tDCS in stroke patients. (Neuromodulation: Technology at the Neural Interface)

Column Highlights Research and Industry Developments Presented at Neuromodulation Meeting

February 2017 - A business column summarizes highlights from the 2017 annual meeting of the North American Neuromodulation Society, held in January. (Neurotech Reports)

Company Developing a Non-invasive Neurostimulator Raises Nearly $10 million

Feb. 16, 2017 - Helius Medical Technologies raised nearly $10 million in a public offering. The company plans to complete a clinical trial of its portable neurostimulator in treating mild to moderate traumatic brain injury. In addition, the company plans new clinical trials in multiple sclerosis and cognition, and to submit an FDA application. (Mass Device)

Startup Would Use Ultrasound to Non-Invasively Stimulate Vagus Nerve

Feb. 11, 2017 - A doctor and an engineer have begun investigating non-invasive stimulation of the vagus nerve through their startup company, Acuta Technologies. An article describes their interest in applying the technology to potentially address diabetes, or control appetite or inflammation. (Minneapolis Star Tribune)

Researchers Build Computer Model of Motor Circuits to Optimize Deep Brain Stimulation

Feb. 10, 2017 - In a research project at University College Dublin, a team is modeling the brain-to-muscle pathway as a way to develop smarter, closed-loop deep brain stimulation devices for Parkinson's disease. The article says there are some 2 million possible stimulation parameters, and the research is intended to help select optimal ones. (Silicon Republic)

Clinical Trial Will Examine Effect of Transcranial Magnetic Stimulation on Fear and Anxiety

Jan 24, 2017 - The National Institute of Mental Health is recruiting up to 126 healthy volunteers for a clinical trial to explore whether transcranial magnetic stimulation to the dorsolateral prefrontal cortex can reduce fear and anxiety. (Clinicaltrials.gov)

Company Developing Non-Invasive Stimulator Plans Public Offering

Feb. 10, 2017 - Helius Medical Technologies plans a public offering on the Toronto Stock Exchange that could bring in about Can$10.8 million. The company also announced publication of a pilot study of its non-invasive stimulator in patients with multiple sclerosis. (Seeking Alpha)

Marketing Clearance Received for Device to Improve Gait

Feb. 8, 2017 - A Bioness system that provides stimulation to assist with gait received FDA clearance. The system includes feedback and a learning algorithm to correct gait as a patient moves. (FDA News)

Brain-Computer Interface Research Attempts to Help Patients with Locked-In Syndrome Communicate

Feb. 7, 2017 - A researcher at the Wyss Center for Bio and Neuroengineering in Geneva is developing an EEG monitoring system for otherwise uncommunicative patients who have locked-in syndrome to respond to yes-or-no questions. (Extreme Tech)

Visual Prosthesis Research Explores Magnetic Stimulation

Feb. 7, 2017 - A magnetic micro-coil developer, PARC, announced unspecified funding from the National Institutes of Health through the U.S. BRAIN Initiative to develop a visual prosthetic in collaboration with the Massachusetts General Hospital, Harvard Medical School, and the University of Florida. The announcement said the funding is "a multi-year, multi-million dollar award". (Globe Newswire)

Article Highlights Importance of Data Analytics for Devices That Employ Neurosensing

Feb. 7, 2017 - An article says data analytics can help neurosensing applications to improve devices to address a number of conditions, such as helping store limb motion after spinal injury. (Healthcare IT)

Retinal Prosthesis Company Raises Funds

Feb. 6, 2017 - Second Sight Medical announced plans for a rights offering to raise additional funds to further develop its retinal prosthesis and expand the market to better-sighted patients who have retinitis pigmentosa. The company announced a decision by the German Institute for the Hospital Renumeration System last week that allows approved hospitals to negotiate for reimbursement by insurers for treatment of patients with advanced retitinitis pigmentosa. (Mass Device)

Company Seeks Regulatory Approval for Sacral Nerve Stimulation System

Feb. 1, 2017 - Nuvectra Corporation filed regulatory submissions with the FDA and CE mark authorities for its sacral nerve stimulation system to treat chronic urinary retention or overactive bladder symptoms. (Nasdaq)

Germany's First Patient Receives First Implant for Disabling Chronic Low Back Pain

Jan. 31, 2017 - Mainstay Medical International plc announced the first sale and implant of its neurostimulation system for disabling chronic low back pain in Germany. (Business Wire)

Cleveland Starts a Brain Health Initiative

Jan. 27, 2017 - The Cleveland Foundation is awarding $15. million grant to Case Western Reserve University to start a multi-institution Cleveland Brain Health Initiative. An article about the grant mentions a federal grant for stroke research by International Neuromodulation Society member Andre Machado, MD, PhD, chair of the Cleveland Clinic Neurological Institute.  (Cleveland Business)

Proof-of-Principle Study Explores Non-invasive Brain Stimulation for Bulimia Patients

Jan. 25, 2017 - A proof-of-principle clinical trial of transcranial direct current stimulation showed effects on bulimia symptoms the day after active stimulation, compared to sham, according to results in 39 patients. The results were reported in PLoS ONE. (Healio)

Study: Most Spinal Cord Stimulation Recipients Do Not Increase Opioid Use

Jan. 24, 2017 - An analysis of medical claims from 5,476 patients who received a spinal cord stimulator showed opioid use declined or stabilized in 70% of them, according to a study sponsored by Abbott and presented at the North American Neuromodulation Society annual meeting. (Pain News Network)

Physician Investigating Potential Benefits of Vagus Nerve Stimulation in Head Injury Patients

Jan. 24, 2017 - A physician has started a clinical trial for up to 30 patients who have had a traumatic brain injury or concussion, in order to investigate transcutaneous vagus nerve stimulation (VNS). Daily VNS sessions address cognitive or functional symptoms ascribed to "abnormal electrical currents in the brain," a news article says. (Minnesota Daily)

Company Prepares to Test Non-invasive Neuromodulation Device in Neuromotor Spasticity

Jan. 23, 2017 - PathMaker Neurosystems Inc. announced it will start a clinical trial in Paris of a non-invasive neuromodulation device to treat neuromotor spasticity. (Business Wire)

Peripheral Neurostimulation Studied in Post-Stroke Shoulder Pain

Jan. 21, 2017 - In a poster presentation at the annual meeting of the North American Neuromodulation Society, data on seven patients with post-stroke shoulder pain were presented. The data showed an average 70% reduction in the patients' pain, as rated in a visual analogue scale, following treatment with a peripheral neurostimulator. (National Pain Report)

Device Company Targeting Weight Loss Raises $19 Million

Jan. 19, 2017 - The company EnteroMedics Inc. announced it raised $19 million in an oversubscribed public offering. The company is commercializing a vagus nerve stimulation system for weight loss. (Mass Device)

Company Makes a Dorsal Root Ganglion Stimulator Available in Europe

Jan. 18, 2017 - St. Jude Medical, which is now part of Abbott, announced it is releasing a dorsal root ganglion stimulation system in Europe. (Medgadget)

New Prize in Neuromodulation Announced

January 2017 - A Science & PINS Prize for Neuromodulation was established in 2016 to honor contributions to neuromodulation research. Recipients will be honored annually for outstanding research as described in an essay based on research performed in the past three years. The award carries a prize of $25,000 and publication of the essay in Science Online, which is published by the nonprofit American Association for the Advancement of Science. Beijing PINS Medical Equipment Co. Ltd. develops nerve stimulation technologies. (Science)

Health Canada Approves a Rechargeable Sacral Neuromodulation System

Jan. 5, 2017 - Axonics Modulation Technologies, Inc. announced it received medical device approval  from Health Canada for its rechargeable sacral neuromodulation system to treat overactive bladder, fecal incontinence and urinary retention. (Yahoo Finance)

Vagus Nerve Stimulation Approach Blocks Unwanted Nerve Conduction

Jan. 5, 2017 - Biomedical engineers at Georgia Tech have designed a pair of vagus nerve stimulation electrodes that block stimulation in an afferent direction and force stimulation to only go in an efferent direction in order to lower inflammatory effects. The blocking electrode uses kilohertz frequency to block unwanted nerve conduction. (Medical Xpress)

First Patient Receives Implant in Clinical Trial of Deep Brain Stimulation for Motor Recovery After Stroke

Jan. 5, 2017 - International Neuromodulation Society member Andre Machado, MD, PhD, is interviewed for a news story about the first stroke patient to be implanted with a deep brain stimulation (DBS) system in his clinical trial of DBS in stroke recovery. The study will investigate if DBS and physical therapy combined help regain motor function. (WOIO)

Review: Non-invasive Neuromodulation is Useful for Migraine Management

January 2017 - A review of non-invasive stimulation in migraine treatment concludes, "Noninvasive neuromodulation is an exciting and useful method that is being increasingly recognised as a valid strategy for migraine management." (touch Neurology)

Small Study Shows Positive Results for Treating Depression in Elderly with Transcranial Magnetic Stimulation

Jan. 3, 2017 - A placebo-controlled study of 52 patients over the age of 60 who have treatment-resistant depression showed that deep transcranial magnetic stimulation led to half the patients achieving full remission, compared to only 16% of the sham-treated patients. (Nasdaq)

Journal Publishes New Consensus on Neuromodulation Therapy

Jan. 2, 2017 - The International Neuromodulation Society journal, Neuromodulation: Technology at the Neural Interface, has published updated guidelines for neurostimulation implants and intrathecal drug delivery. The six articles appear in Early View, and were authored by the Polyanalgesic Consensus Conference and the Neurostimulation Appropriateness Consensus Committee. These more than 60 international experts were convened by the INS Executive Board to provide guidance for improving safety and efficacy of these therapies that can help reduce opioid use. The authors reviewed publications that appeared in the scientific literature by 2014 to issue the updated guidance. (News-Medical.net)

Last Updated on Friday, February 24, 2017 03:51 PM